(6-338) Cyclin-dependent Mediator Kinases CDK8/19 Are Essential for Transcriptional Reprogramming That Leads to Resistance to Lapatinib Treatment in HER2-positive Breast Cancer
Tuesday, December 5, 2023
10:45 AM – 11:45 AM
Location: Hall E, Lower Level
Co-Author(s): Gary Schools, Eugenia Broude, Zachary Mack, Amanda Sharko
